Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corporation Reports Second Quarter
February 6, 2017 4:15 PM ESTTEANECK, N.J., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2016.
Highlights for the December 2016 quarter (compared to the December 2015 quarter)
Net sales of $192 million, equal to the prior yearNet income of $13 million, a decrease of $16.8 million, or 56%Diluted EPS of $0.34, a decrease of $0.41, or 56%Adjusted EBITDA of $31 million, an increase of $3 million, or 10%Adjusted diluted EPS of $0.39, an increase of $0.02, or 5%ÂCOMMENTARY
We are very... More



